(Press-News.org) Patients with obstructive sleep apnea (OSA) may blame their daytime difficulties on simple sleepiness, but new research suggests that their brains may be to blame. Specifically, their cognitive challenges may be caused by structural deficits in gray matter, brought on by the intermittent oxygen deprivation that comes with OSA. The good news is that these deficits may be partially or fully reversible with early detection and treatment, according to Italian researchers.
"OSA patients demonstrate several neuropsychological impairments, but current knowledge of the brain structures affected by OSA is limited. This study provides the first evidence that structural brain abnormalities exist in regions susceptible to hypoxemia, and they can change with treatment," said Vincenza Castronovo, Ph.D., clinical psychologist at the Sleep Disorders Center, Vita-Salute San Raffaele University and San Raffaele Scientific Institute in Milan, Italy.
The study was published online ahead of the print edition of the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
To determine whether there were quantifiable structural differences in the brains of OSA patients when compared to individuals without OSA, and whether any differences found could be reversed with treatment, researchers compared 17 treatment-naïve individuals with severe OSA and 15 age-matched controls. They gathered baseline measurements of brain anatomy using MRI, as well as individual performance on cognitive performance tests that assessed short- and long-term memory, executive functions, constructional abilities, vigilance, attention and abstract reasoning. The subjects also completed the Epworth Sleepiness Scale to assess daytime sleepiness and the Beck Depression Inventory to evaluate mood.
The researchers found significant reductions in gray matter (GM) between OSA and non-OSA subjects. Moreover, the specific locations of the deficits indicated that specific brain functions were more strongly affected than others, including executive function (which controls high-order brain functions such as problem-solving) and abstract reasoning.
"We found reduced GM in the OSA group when compared to the non-OSA group in several key regions of the brain," said Dr. Castronovo. "Of particular note were the deficits in the left parahippocampal gyrus and in the left posterior-parietal cortex. We found that these two regions have significant bearing on abstract reasoning and executive function. Deficits in the left posterior-parietal cortex were also shown to be associated with daytime sleepiness."
They also found that on tests, subjects with OSA demonstrated impairments in memory, attention, executive functions and constructional abilities and had higher sleepiness scores.
Remarkably, however, treatment with continuous positive airway pressure (CPAP), seemed to reverse these damages. After three months of treatment, the subjects in the OSA group were evaluated again. There was a GM-volume increase in the left anterior parahippocampal gyrus, which was associated with improved performance on tests of short-term memory and executive function. OSA subjects who had undergone treatment also had gains in the right cornu-ammonis and the enthorinal-cortex bilaterally, both of which were associated with improvements in executive function. Indeed, the researchers observed significant cognitive improvement in all domains.
While previous studies have published contrary findings, Dr. Castronovo pointed out that with the increasing sensitivity of neuroimaging software, more sensitive analyses and robust results are now possible.
"These results suggest a scenario in which the hippocampus, due to its sensitivity to hypoxia and innervation of small vessels, is the region that is most strongly and quickly affected by hypoxic episodes," said Dr. Castronovo. "The mechanism of the observed brain changes could be either neurogenic or vasogenic," she continued. "We propose it to be vasogenic."
Further research will be necessary to bear out Dr. Castronovo's theory. If it is borne out, it could open new doors for treatment, such as steroid therapy.
"Next, our group will focus on increasing our understanding of brain damage and recovery," said Dr. Castronovo. "We want to evaluate non-hypoxic sleep disordered breathing in sleepy patients to assess the role of hypoxia in structural brain involvement."
INFORMATION:
END
ESA GlobSnow project led by the Finnish Meteorological Institute uses satellites to produce up-to-date information on global snow cover. The new database gives fresh information on the snow situation right after a snowfall. Gathering this information was not possible before when only land-based observations were available.
European Space Agency´s (ESA) GlobSnow project, led by the Finnish Meteorological Institute, can map the extent and volume of snow cover especially on the northern hemisphere. Launched at the beginning of November, the service provides almost real-time ...
The brain, a complex network
The human brain is composed of 100 billion individual nerve cells which communicate with each other via a complex network of connections. Errors in communications of these cells are often at the basis of brain and nerve diseases such as Alzheimer's and multiple sclerosis. In the search for possible solutions to these diseases, one important aspect is to understand how the connections between nerve cells develop.
Drosophila as a model organism
The fruit fly, Drosophila melanogaster, is an important, low-cost model organism with 60% genetic ...
Powdery mildew is a fungus that infects both crop and ornamental plants. Each year, powdery mildew and other plant pathogens cause immense crop loss. Despite decades of intense research, little is known of the plant molecules that allow fungal hyphae to invade the host's epidermal cells. A European research group lead by Ueli Grossniklaus, a plant geneticist at the University of Zurich, now published a study in Science shedding a new light on mildew susceptibility in plants and its surprising link to reproduction.
Investigating mildew susceptibility in plants is not really ...
ANN ARBOR, Mich. — Urinary tract infections are a painful, recurring problem for millions of women. They are also getting more dangerous as bacteria develop resistance to the most common treatments.
Scientists from the University of Michigan have moved one step closer to a vaccine that could prevent a majority of urinary tract infections, which are caused by E. coli bacteria. Using a genetic technique rarely used to look at infections in human hosts, the researchers studied how the E. coli bacteria operate and discovered key differences between how the bacteria's genes ...
History's first recognized influenza pandemic originated in Asia and rapidly spread to other continents 500 years ago, in the summer of 1510. A new commentary by researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, explores the 1510 pandemic and what we have learned since then about preventing, controlling and treating influenza.
Prior to that time, regional and local epidemics of respiratory infectious diseases and pneumonia had occurred, but no outbreaks had yet been recorded on a worldwide scale. The 1510 ...
A collaboration between a physician-researcher at Massachusetts General Hospital (MGH) and a mathematician from Harvard University has led to development of a mathematical model reflecting how red blood cells change in size and hemoglobin content during their four-month lifespan. In their report published online in PNAS Early Edition, John Higgins, MD, MGH Center for Systems Biology and Department of Pathology, and L. Mahadevan, PhD, Harvard School of Engineering and Applied Sciences (SEAS), also describe how their model may be used to provide valuable clinical information.
"This ...
Geneva, Switzerland, 12 November 2010 – Allosteric modulation company Addex Pharmaceuticals (SIX:ADXN) announced today that data on a total of nine therapeutic programs will be presented during Society for Neuroscience 2010 (November 13-17, San Diego, USA), highlighting the strength of its allosteric modulation technology platform. The data being presented cover multiple receptor types and therapeutic areas, including Parkinson's disease, schizophrenia, anxiety, Alzheimer's disease and depression.
"The data generated by Addex and our partners, Ortho-McNeil-Janssen and ...
COLLEGE STATION -- A virus that normally deforms or kills plants like tomatoes, peppers and eggplants isn't all bad: A gene within the virus has been found useful for allowing foreign genes to be introduced into a plant without harmful effects, according to Texas AgriLife Research scientists.
The technology ultimately could lead the way toward a "cheap, green alternative" for pharmaceutical development, said Dr. Herman Scholthof, AgriLife Research virologist.
Scholthof and colleague Drs. Yi-Cheng Hsieh and Veria Alvarado collaborated with scientists at the John Innes ...
Chemical reactions are happening all over the place all the time--on the sun, on the Earth and in our bodies. In many cases, enzymes help make these reactions occur. One family of enzymes, called cytochrome P450s (P450), is important because they help us eliminate toxins.
We know P450s are important to life of all kinds because they have been found in animals, plants, fungi and bacteria, but they are of special interest to humans because they are responsible for metabolism of about 75 percent of known pharmaceuticals.
"The reactions that P450s perform to detoxify a ...
PHILADELPHIA - The potential for harmful side effects associated with anti-psychotic medications for treating schizophrenia is a frustration for mental-health professionals who must balance this with the positive benefits of drugs. For example, the issue of the antipsychotic drug ziprasidone lengthening the QTc interval, a possible indicator of life-threatening heart arrhythmias, has demanded much attention among clinicians since the drug was introduced in 2001.
Ziprasidone (marketed as Geodon and Zeldox by Pfizer Inc.) was the fifth second-generation anti-psychotic ...
